High Dose Flu Vaccine Better Protection for Older Adults with Diabetes

Share:

Medical News Updates

Education


In this episode of Medical News Update, we discuss a recent study from Denmark examining the efficacy of high-dose inactivated influenza vaccines in adults aged 65 and older, particularly those with diabetes. The study reveals that high-dose vaccines lead to fewer cardiorespiratory and cardiovascular hospitalizations compared to standard-dose vaccines. While the exact benefits vary, the findings suggest that a high-dose approach is beneficial for older adults, especially those with long-standing diabetes. The episode also highlights current CDC recommendations for flu vaccination in older adults.


00:00 Introduction to Today's Topic

00:03 The Importance of Flu Vaccination for High-Risk Groups

00:17 Background on Influenza and Cardiovascular Risks

00:45 Details of the Danish Study (DANFLU-2)

01:45 Key Findings and Results

03:43 Implications for Clinical Practice

04:32 Conclusion and Final Thoughts